この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2023/5/51 分で読めます
Prospective Grant of an Exclusive Patent License: Predicting Patient Response to Cancer Therapy via Histopathology Images
ローカル自動翻訳 · 情報源の原言語
概要
The National Cancer Institute (NCI), an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Australian National University ("ANU"), a non-profit research institution located in Canberra, Australia for NCI's rights to the patent applications listed in the Supplementary Information section of this notice.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →